Precise gene editing in human embryos advances, but ethical debates intensify

Scientists have achieved a significant breakthrough in gene editing, successfully correcting disease-causing genes in human embryos with unprecedented precision. A collaborative effort between researchers in South Korea and the United States has employed a technique called base editing, which modifies a single DNA base rather than cutting the entire DNA strand, as was done with earlier CRISPR-Cas9 methods.

“

This research represents a conceptual leap forward in this field.

This advanced approach dramatically minimizes the risk of side effects, such as chromosomal damage, which were a concern with previous gene-editing technologies. The research team, involving institutions like Seoul National University, Korea University, and the Institute for Basic Science (IBS), focused on correcting genes linked to high cholesterol and blood disorders in human embryos. Crucially, their experiments demonstrated that the edited embryos could develop normally to the blastocyst stage, just before implantation in the uterus, without the growth arrest that plagued earlier attempts.

The development builds upon previous, more controversial gene-editing efforts, notably the 2018 announcement by Chinese scientist He Jiankui, who used the first-generation CRISPR-Cas9 technology to create the world's first gene-edited babies. That experiment faced widespread condemnation due to potential for severe side effects and ethical concerns.

“

Gene-edited babies are the greatest biotechnology innovation of the last century.

While this new base editing technique shows promising safety improvements, it is not without its challenges. A phenomenon known as mosaicism, where not all cells in the embryo are edited uniformly, was still observed. Additionally, unintended off-target mutations were detected in some instances. Researchers acknowledge that the technology is not yet ready for clinical application due to these concerns.

“

The experiment improved the procedure by injecting the gene-editing tools as a pre-made protein-RNA complex (RNP) instead of mRNA, which the cells recognized as foreign invaders and stopped development.

The advancement has reignited intense ethical debates. Concerns linger about the potential misuse of this technology for creating 'designer babies' with enhanced traits like appearance or intelligence, rather than solely for treating genetic diseases. Experts warn of the possibility of unforeseen consequences and the ethical implications of altering the human germline, emphasizing the need for careful consideration and regulation.

“

We cannot apply it to clinical practice at the moment.